Latest "Morgan Properties" News Stories
Here are the most relevant search results for "Morgan Properties" found in our extensive news archives from over 250 global news sources.
More Information about Morgan Properties on BioPortfolio
In addition to our news stories we have dozens of PubMed Articles about Morgan Properties for you to read. Along with our medical data and news we also list Morgan Properties Clinical Trials, which are updated daily. BioPortfolio also has a large database of Morgan Properties Companies for you to search.
Showing "Morgan Properties" News Articles 1–25 of 2,200+
NatureWorks Names Richard Altice New President and CEO
Altice joins company as it continues market-leading growth and innovation. NatureWorks’ board of directors named Richard Altice as the company’s new President and Chief Executive Officer, replacing Marc Verbruggen, who led the company from 2008 to his retirement in 2017. Altice comes to NatureWorks from PolyOne Corporation where he ...
TAICANG, China, April 24, 2018 /PRNewswire/ -- Connect Biopharmaceuticals, Ltd. today announced that it has submitted an application in Australia to begin a phase 1 clinical trial to evaluate CBP-201, the company's monoclonal antibody candidate for allergic inflammation. The planned phase 1 clinical trial is a randomized, double-blind, placebo-controlled study in healthy subjects to evaluate the ...
EY announced that Geoff Gross, Founder & CEO of Medical Guardian, a leading provider of innovative medical alert systems, is a finalist for the Entrepreneur Of The Year® 2018 Award in the Greater Philadelphia region. This is the fourth year in a row Geoff has been named a finalist of EY’s Entrepreneur of the Year Award. “I’m honored to ...
Simulations Plus Announces Employee Bonuses
Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for all stages of pharmaceutical discovery and development, today announced that it will be distributing a one-time $1,000 discretionary cash bonus to each of its employees. Walt Woltosz, chairman and chief executive officer of Si...
Dr. Sarah Leary, pediatric oncologist at Seattle Children’s Hospital, completes trial of Tumor Paint BLZ-100 in 28 children undergoing brain tumor removal surgery Gateway for Cancer Research (Gateway), a non-profit dedicated to funding transformational cancer research, announces the completion of a Phase I clinical project led by Dr. Sarah ...
Cosmeist is preparing to launch both its Moist and Smooth Amino Mason lines of rose-scented hair care products, each packed with amino acids and forest botanicals carefully selected to create silky smooth, luminous hair, into the U.S. marketplace. BOCA RATON, Fla. (PRWEB) April 24, 2018 Cosmeist is preparing to launch both its Moist and Smooth Amino Mason lines of rose-scented hair care products,...
New compound could offer pain-relieving properties without risk of addiction
Researchers at the University of Michigan have engineered a new compound that animal tests suggest could offer the pain-relieving properties of opioids such as morphine and oxycodone without the risk of addiction.
Studies show hemp's potential for treating ovarian cancer
Results from some of the first studies to examine hemp's ability to fight cancer show that it might one day be useful as plant-based treatment for ovarian cancer. Hemp is part of the same cannabis family as marijuana but doesn't have any psychoactive properties or cause addiction.
Bank-Chef Lloyd Blankfein will seine Kunden beim Handel mit Bitcoin und Co. unterstützen. Damit grenzt er sich klar von JP-Morgan-Chef Dimon ab.Lloyd Blankfein hat sich von Anfang an alle Türen off...
DGAP-News: MorphoSys AG / Key word(s): Corporate Action/IPO 23.04.2018 / 22:05 The issuer is solely responsible for the content of this announcement. Planegg/Munich, Germany, April 23, 2018 MorphoSys Announces Closing of Nasdaq IPO through an ADS Offering and Exercise of the Underwriters' Option to Purchase Additional ADSs, Leading to Total Gross Proceeds of USD 239 million MorphoSys ...
Ranexa API Insight,2018 [Report Updated: 14022018] Prices from USD $500
IntroductionDelveInsight's, Ranexa API Insight, 2018 report provides product and API manufacturers' details across the globe along with the location. The report gives the clear idea on the country wise DMF filed by worldwide companies related to Ranexa . The report also highlights the patent details of Ranexa . MethodologyThe report is built using data and information sourced from proprietary da...
Promise for safer opioid pain reliever
Researchers have engineered a new compound that animal tests suggest could offer the pain-relieving properties of opioids such as morphine and oxycodone without the risk of addiction.
Apple-Aktie: Kursschwächen nach Quartalsbericht ausnutzen!
New York - Apple-Aktienanalyse von Analystin Katy Huberty von Morgan Stanley: Analystin Katy Huberty von Morgan Stanley bestätigt im Rahmen einer Aktienanalyse ihre Übergewichten-Empfehlung für die...
EY has announced that Dawn Zier, CEO of Nutrisystem, Inc. (NASDAQ: NTRI), a leading provider of weight management products and services including Nutrisystem® and South Beach Diet® brands, is a finalist for the Entrepreneur Of The Year® 2018 Award in the Greater Philadelphia Region. The awards program recognizes entrepreneurs who are excelling in areas ...
Kaleido Biosciences Announces Appointment of Joshua Brumm as Chief Financial Officer
Kaleido Biosciences, a clinical-stage biotechnology company developing novel chemistries to unlock the power of the human microbiome, today announced the appointment of Joshua Brumm as chief financial officer. Mr. Brumm, an accomplished CFO with extensive financial and operational experience, will report directly to chief executive officer and chair, Micha...
CBT Pharmaceuticals (CBT), a U.S. and China-based innovative biopharmaceutical company committed to becoming a leader in the discovery and development of oncology combination therapies, and CrystalGenomics, Inc., (KOSDAQ:083790), a Korea-based biopharmaceutical company with drug discovery, development and commercialization capabilities, today announced ...
Annual Report 2017 Active Biotech AB (publ)
PRESS RELEASE Active Biotech's Annual Report 2017 is now available för download at www.activebiotech.com. The Annual Report will only be digitally distributed. The English version will be available within short. Lund, April 23, 2018 Active Biotech AB (publ) Helén TuvessonCEO For further information, please contact:Hans Kolam, CFOTel. +46 (0)46 192044 About ...
Wood properties improved for biofuel production
Scientists at the Forest Biotechnology Group at North Carolina State University can now predict the results from modifying 21 -More-
Zhejiang Teruisi Biopharmaceutical to take the lead in developing the program in China, Epimab retains worldwide commercial rights outside of China EpimAb Biotherapeutics, a Shanghai-based biopharmaceutical company specializing in bispecific antibodies, and Zhejiang Teruisi Biopharmaceutical, a company specialized in the development of biologics...
Vivanza API Insight,2018 [Report Updated: 14022018] Prices from USD $500
IntroductionDelveInsight's, Vivanza API Insight, 2018 report provides product and API manufacturers' details across the globe along with the location. The report gives the clear idea on the country wise DMF filed by worldwide companies related to Vivanza . The report also highlights the patent details of Vivanza . MethodologyThe report is built using data and information sourced from proprietary...
Sensipar API Insight,2018 [Report Updated: 14022018] Prices from USD $500
IntroductionDelveInsight's, Sensipar API Insight, 2018 report provides product and API manufacturers' details across the globe along with the location. The report gives the clear idea on the country wise DMF filed by worldwide companies related to Sensipar . The report also highlights the patent details of Sensipar . MethodologyThe report is built using data and information sourced from propriet...
Hemp shows potential for treating ovarian cancer
(Experimental Biology 2018) Results from some of the first studies to examine hemp's ability to fight cancer show that it might one day be useful as plant-based treatment for ovarian cancer. Hemp is part of the same cannabis family as marijuana but doesn't have any psychoactive properties or cause addiction.
Baraklyud API Insight,2018 [Report Updated: 14022018] Prices from USD $500
IntroductionDelveInsight's, Baraklyud API Insight, 2018 report provides product and API manufacturers' details across the globe along with the location. The report gives the clear idea on the country wise DMF filed by worldwide companies related to Baraklyud . The report also highlights the patent details of Baraklyud . MethodologyThe report is built using data and information sourced from propr...
Abemaciclib Launch Insight, 2018 [Report Updated: 14022018] Prices from USD $1500
DelveInsight's, Abemaciclib, Launch Insight, 2018 report provides comprehensive Insight about the Abemaciclib's launch. The report covers all the indications for which the Abemaciclib is being developed and also provides the competitive landscape for the major indications. The report further includes patent details, forecasted sales till 2022 and post launch market positioning. The report will pro...
SummaryOvensa Inc Ovensa is a preclinical stage company that develops nanotherapeutics. The company uses its proprietary Triozan nanomedicine delivery platform that has mucosal and brainbarrier crossing properties used in treatment of oncology and neurodegenerative diseases. Its Triozan helps in the efficient delivery of a wide range of drugs across multiple barriers such as blood brain barrier, b...
